1. null
   Laurence Booth et al, 2018 CrossRef
2. NKG2D and its ligands in cancer
   Payal Dhar et al, 2018, Current Opinion in Immunology CrossRef
3. Analysis of programmed death-ligand 1 expression in primary normal human dermal fibroblasts after DNA damage
   Yoshihiko Hagiwara et al, 2018, Human Immunology CrossRef
4. Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells.
   Tae Woo Kim et al, 2018, Cell Death Dis CrossRef
5. Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B
   Huizi Keiko Li et al, 2018, Biochemical and Biophysical Research Communications CrossRef
6. Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth
   Tsui Mao et al, 2019, IJMS CrossRef
7. Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
   Maxim Shevtsov et al, 2019, Front. Oncol. CrossRef
8. High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway
   Qingke Duan et al, 2019, J Exp Clin Cancer Res CrossRef
9. Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
   Hiro Sato et al, 2020, Int J Clin Oncol CrossRef
10. null
    Ester Munera-Maravilla et al, 2020 CrossRef
11. Modulation of immune responses by DNA damage signaling
    Yuki Uchihara et al, 2021, DNA Repair CrossRef
12. Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells
    Harpreet K Mandhair et al, 2021, WJSC CrossRef
13. G9a: An Emerging Epigenetic Target for Melanoma Therapy
    Jessica L. Flesher et al, 2021, Epigenomes CrossRef
14. Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells
    Moyra Lawrence et al, 2022, Sci. Adv. CrossRef
15. Characterizing HDAC Pathway Copy Number Variation in Pan-Cancer
    Shuming Yang et al, 2022, Pathol. Oncol. Res. CrossRef
16. Value of Carbon-ion Radiotherapy for early stage non-small cell lung cancer
    Hanguang Ruan et al, 2022, Clinical and Translational Radiation Oncology CrossRef
17. Stress-induced MICA and MICB molecules in oncology
    S. A. Yurevna et al, 2022, Med. immunol. CrossRef
18. The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention.
    Rafat El-Awady, 0 CrossRef
19. Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma
    Yu-Fan Liu et al, 2022, Front. Oncol. CrossRef
20. Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
    Filipa D. dos Reis et al, 2023, Front. Immunol. CrossRef
21. A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors
    John Goulding et al, 2023, Med CrossRef
22. Regulation of DNA damage-induced HLA Class I Presentation
    Yuki Uchihara et al, 2023, DNA Repair CrossRef